REX:NYE-REX American Resources Corporation (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 42.68

Change

-0.29 (-0.67)%

Market Cap

N/A

Volume

0.08M

Analyst Target

USD 95.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

-0.19 (-1.65%)

USD 1.94B
BAK Braskem SA Class A

-0.01 (-0.27%)

USD 1.44B
WLKP Westlake Chemical Partners LP

-0.01 (-0.05%)

USD 0.79B
TROX Tronox Holdings PLC

+0.02 (+0.35%)

USD 0.75B
ASIX AdvanSix Inc

-0.17 (-0.72%)

USD 0.62B
VHI Valhi Inc

-0.08 (-0.54%)

USD 0.43B
RYAM Rayonier Advanced Materials

N/A

USD 0.26B
DOW Dow Inc

-0.10 (-0.35%)

N/A
CE Celanese Corporation

-0.15 (-0.27%)

N/A
LXU Lsb Industries Inc

-0.14 (-1.77%)

N/A

ETFs Containing REX

PUW 0.00 % 0.70 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.37% 100% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.37% 100% F 64% D
Trailing 12 Months  
Capital Gain -8.74% 82% B 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.74% 82% B 20% F
Trailing 5 Years  
Capital Gain 77.27% 91% A- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.27% 91% A- 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.02% 62% D 76% C+
Dividend Return 12.02% 62% D 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.61% 62% D 29% F
Risk Adjusted Return 39.26% 77% C+ 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike